Good Quality Doxycycline Mono 100mg Tablet - Rosuvastatin Calcium – CPF
Good Quality Doxycycline Mono 100mg Tablet - Rosuvastatin Calcium – CPF Detail:
瑞舒伐他汀钙 | Rosuvastatin Calcium | 147098-20-2 | In-House/CEP |
RSM(Crystal) | 147118-40-9 | In-House | |
RSM(Crude) | 147118-40-9 | In-House | |
RSP | — | In-House | |
RS-8 | 147118-36-3 | In-House | |
RS-8-1 | 147118-37-4 | In-House | |
TP-8 | 131466-61-0 | In-House | |
TP-11 | 147118-35-2 | In-House | |
TP-13 | 147118-39-6 | In-House | |
RS-10 | 289042-12-2 | In-House | |
RS-11 | 355806-00-7 | In-House |
Description
Rosuvastatin Calcium (BANM, JAN, USAN) is known as Rosuvastatin in the US. and a competitive HMG-CoA reductase inhibitor with an IC50 of 11 nM[1]. Rosuvastatin Calcium potently blocks human ether-a-go-go related gene (hERG) current with an IC50 of 195 nM, delayed cardiac repolarization, and thereby prolonged action potential durations (APDs) and corrected QT interval (QTc) intervals[2]. Rosuvastatin Calcium reduces the expression of the mature hERG and the interaction of heat shock protein 70 (Hsp70) with the hERG protein. Rosuvastatin Calcium is very effective in lowering low-density lipoprotein (LDL) cholesterol, triglycerides, and C-reactive protein levels[3].
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
In the US, Rosuvastatin (rosuvastatin systemic) is a member of the drug class statins and is used to treat Atherosclerosis, High Cholesterol, High Cholesterol – Familial Heterozygous, High Cholesterol – Familial Homozygous, Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa – Elevated LDL, Hyperlipoproteinemia Type IIb – Elevated LDL VLDL, Hyperlipoproteinemia Type III – Elevated beta-VLDL IDL, Hyperlipoproteinemia Type IV – Elevated VLDL, Hypertriglyceridemia and Prevention of Cardiovascular Disease.
Background
A selective, competitive inhibitor of HMG-CoA reductase, that is also antilipemic.
Storage
Powder |
-20°C |
3 years |
4°C |
2 years | |
In solvent |
-80°C |
6 months |
-20°C |
1 month |
Chemical structure
Proposal 18 Quality Consistency Evaluation projects which have approved 4, and 6 projects are under approving.
Advanced international quality management system has laid solid foundation for sales.
Quality supervision runs through the whole life cycle of the product to ensure the quality and therapeutic effect.
Professional Regulatory Affairs team supports the quality demands during the application and registration.
VIEW MORE
VIEW MORE
International cooperation
Domestic cooperation
Product detail pictures:
Related Product Guide:
As for aggressive costs, we believe that you will be searching far and wide for anything that can beat us. We can state with absolute certainty that for such high-quality at such rates we have been the lowest around for Good Quality Doxycycline Mono 100mg Tablet - Rosuvastatin Calcium – CPF , The product will supply to all over the world, such as: Kenya, Japan, Brasilia, By integrating manufacturing with foreign trade sectors, we can provide total customer solutions by guaranteeing the delivery of right products to the right place at the right time, which is supported by our abundant experiences, powerful production capability, consistent quality, diversified products and the control of the industry trend as well as our maturity before and after sales services. We'd like to share our ideas with you and welcome your comments and questions.
By Lena from Uruguay - 2017.11.20 15:58
High production efficiency and good product quality, fast delivery and completed after-sale protection, a right choice, a best choice.
By Eileen from Swansea - 2018.06.12 16:22